Pneumagen

Pneumagen is a clinical-stage biotech company that focuses on developing glycan targeted carbohydrate-binding modules (CBMs) for the prevention and treatment of respiratory tract infections (RTIs) and cancer. Their lead product, Neumifil, is an intranasal drug designed to prophylaxis and treat a broad range of viral RTIs. Pneumagen's mission is to develop innovative, life-saving antiviral therapie...